Homologous equivalence study of immunogenicity after third dose of Covid-19 vaccine (recombinant) with an interval of six months after the second dose, comparing the interval of eight and 12 weeks between the first two doses-Reference-Cited by-同舟云学术

Homologous equivalence study of immunogenicity after third dose of Covid-19 vaccine (recombinant) with an interval of six months after the second dose, comparing the interval of eight and 12 weeks between the first two doses

Published:2024 Issue: Volume:119 Page:
ISSN:1678-8060
Container-title:Memórias do Instituto Oswaldo Cruz
language:
Short-container-title:Mem. Inst. Oswaldo Cruz

Author:

Vianna Clarice Monteiro¹^ORCID,da Silva e Sá Gloria Regina²,Seid Maria Vitória Hadland¹,Camacho Luiz Antonio Bastos¹,Xavier Janaína Reis¹,da Gama Vitor Cardoso¹,de Castro Thalita da Matta¹,dos Santos Ewerton Alves Portela¹,de Almeida Camila Dias¹,Cruz Robson Leite de Souza¹,Siqueira Marilda¹,Maia Maria de Lourdes de Sousa¹,Ferroco Clara Lucy de Vasconcellos¹,de Araújo Mia Ferreira¹,Tort Luis Fernando López³,Caetano Braulia Costa¹

Affiliation:

1. Fundação Oswaldo Cruz-Fiocruz, Brazil

2. Universidade Federal do Estado do Rio de Janeiro, Brazil

3. Fundação Oswaldo Cruz-Fiocruz, Brazil; Universidad de la República, Uruguay

Publisher

FapUNIFESP (SciELO)

Link

http://www.scielo.br/scielo.php?script=sci_pdf&pid=S0074-02762024000101122&tlng=en

Reference15 articles.

1. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey M;Lancet,2021

2. Effectiveness of Covid-19 vaccines against the B 1.617.2 (Delta) variant;Lopez Bernal J;N Engl J Med,2021

3. NOTA TÉCNICA No 43/2021-SECOVID/GAB/SECOVID/MS. Dispõe sobre a administração de dose adicional e de dose de reforço de vacinas contra a Covid-19;Brasília,2021

4. NOTA TÉCNICA No 59/2021-SECOVID/GAB/SECOVID/MS. Dispõe sobre administração de reforço de vacinas contra a Covid-19 em pessoas com mais de 18 anos;Brasília,2021

5. NOTA TÉCNICA No 65/2021-SECOVID/GAB/SECOVID/MS. Dispõe sobre antecipação do intervalo para dose de reforço de vacinas contra a COVID-19 em pessoas com mais de 18 anos e imunossuprimidos;Brasília,2021